CONCENTRA GROUP HOLDINGS PAR (CON) Stock Fundamental Analysis

NYSE:CON • US20603L1026

23.96 USD
+0.32 (+1.35%)
At close: Feb 27, 2026
23.96 USD
0 (0%)
After Hours: 2/27/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

CON gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. While CON belongs to the best of the industry regarding profitability, there are concerns on its financial health. CON has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year CON was profitable.
  • CON had a positive operating cash flow in the past year.
  • CON had positive earnings in 4 of the past 5 years.
  • Of the past 5 years CON 4 years had a positive operating cash flow.
CON Yearly Net Income VS EBIT VS OCF VS FCFCON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

  • With a decent Return On Assets value of 5.33%, CON is doing good in the industry, outperforming 78.22% of the companies in the same industry.
  • CON's Return On Equity of 39.35% is amongst the best of the industry. CON outperforms 95.05% of its industry peers.
  • CON has a better Return On Invested Capital (11.29%) than 85.15% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CON is significantly above the industry average of 9.08%.
  • The last Return On Invested Capital (11.29%) for CON is well below the 3 year average (23.70%), which needs to be investigated, but indicates that CON had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.33%
ROE 39.35%
ROIC 11.29%
ROA(3y)14.38%
ROA(5y)N/A
ROE(3y)62.08%
ROE(5y)N/A
ROIC(3y)23.71%
ROIC(5y)N/A
CON Yearly ROA, ROE, ROICCON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 20 40 60 80 100

1.3 Margins

  • CON's Profit Margin of 7.26% is amongst the best of the industry. CON outperforms 88.12% of its industry peers.
  • In the last couple of years the Profit Margin of CON has declined.
  • The Operating Margin of CON (15.61%) is better than 92.08% of its industry peers.
  • CON's Operating Margin has declined in the last couple of years.
  • The Gross Margin of CON (28.36%) is comparable to the rest of the industry.
  • CON's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 15.61%
PM (TTM) 7.26%
GM 28.36%
OM growth 3Y-3.12%
OM growth 5YN/A
PM growth 3Y-10.09%
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5YN/A
CON Yearly Profit, Operating, Gross MarginsCON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • CON has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • CON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CON Yearly Shares OutstandingCON Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
CON Yearly Total Debt VS Total AssetsCON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 1.95 indicates that CON is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • CON has a Altman-Z score (1.95) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of CON is 9.18, which is on the high side as it means it would take CON, 9.18 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of CON (9.18) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 4.15 is on the high side and indicates that CON has dependencies on debt financing.
  • With a Debt to Equity ratio value of 4.15, CON is not doing good in the industry: 77.23% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 4.15
Debt/FCF 9.18
Altman-Z 1.95
ROIC/WACC1.4
WACC8.09%
CON Yearly LT Debt VS Equity VS FCFCON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 500M 1B

2.3 Liquidity

  • CON has a Current Ratio of 1.20. This is a normal value and indicates that CON is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.20, CON perfoms like the industry average, outperforming 43.56% of the companies in the same industry.
  • CON has a Quick Ratio of 1.20. This is a normal value and indicates that CON is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.20, CON perfoms like the industry average, outperforming 49.51% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.2
CON Yearly Current Assets VS Current LiabilitesCON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.71%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%15.92%

3.2 Future

  • Based on estimates for the next years, CON will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.23% on average per year.
  • CON is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.93% yearly.
EPS Next Y9.96%
EPS Next 2Y11.84%
EPS Next 3Y12.23%
EPS Next 5YN/A
Revenue Next Year7.53%
Revenue Next 2Y6.75%
Revenue Next 3Y6.93%
Revenue Next 5YN/A

3.3 Evolution

CON Yearly Revenue VS EstimatesCON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
CON Yearly EPS VS EstimatesCON Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0.5 1 1.5

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 17.62, CON is valued on the expensive side.
  • Based on the Price/Earnings ratio, CON is valued a bit cheaper than 76.24% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.07, CON is valued a bit cheaper.
  • CON is valuated correctly with a Price/Forward Earnings ratio of 16.02.
  • Based on the Price/Forward Earnings ratio, CON is valued a bit cheaper than 74.26% of the companies in the same industry.
  • CON is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 28.05, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 17.62
Fwd PE 16.02
CON Price Earnings VS Forward Price EarningsCON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 68.32% of the companies in the same industry are more expensive than CON, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, CON is valued a bit cheaper than 71.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.49
EV/EBITDA 11.66
CON Per share dataCON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 15

4.3 Compensation for Growth

  • CON's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • CON has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as CON's earnings are expected to grow with 12.23% in the coming years.
PEG (NY)1.77
PEG (5Y)N/A
EPS Next 2Y11.84%
EPS Next 3Y12.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 1.06%, CON has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 0.48, CON pays a better dividend. On top of this CON pays more dividend than 87.13% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.82, CON's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.06%

5.2 History

  • CON does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
CON Yearly Dividends per shareCON Yearly Dividends per shareYearly Dividends per share 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

  • The earnings of CON are negative and hence is the payout ratio. CON will probably not be able to sustain this dividend level.
DP-991.33%
EPS Next 2Y11.84%
EPS Next 3Y12.23%
CON Yearly Income VS Free CF VS DividendCON Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

Find the best dividend stocksShow peers with best dividend

CONCENTRA GROUP HOLDINGS PAR

NYSE:CON (2/27/2026, 8:04:00 PM)

After market: 23.96 0 (0%)

23.96

+0.32 (+1.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-26
Earnings (Next)05-05
Inst Owners90.19%
Inst Owner Change-4.55%
Ins Owners8.07%
Ins Owner Change11.45%
Market Cap3.07B
Revenue(TTM)N/A
Net Income(TTM)151.68M
Analysts81.82
Price Target28.56 (19.2%)
Short Float %2.99%
Short Ratio3.54
Dividend
Industry RankSector Rank
Dividend Yield 1.06%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-991.33%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.07%
Min EPS beat(2)-2.63%
Max EPS beat(2)2.78%
EPS beat(4)3
Avg EPS beat(4)0.49%
Min EPS beat(4)-2.63%
Max EPS beat(4)2.78%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.13%
Min Revenue beat(2)0.78%
Max Revenue beat(2)1.48%
Revenue beat(4)2
Avg Revenue beat(4)0.34%
Min Revenue beat(4)-0.78%
Max Revenue beat(4)1.48%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.52%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.41%
Valuation
Industry RankSector Rank
PE 17.62
Fwd PE 16.02
P/S 1.47
P/FCF 17.49
P/OCF 12.07
P/B 7.97
P/tB N/A
EV/EBITDA 11.66
EPS(TTM)1.36
EY5.68%
EPS(NY)1.5
Fwd EY6.24%
FCF(TTM)1.37
FCFY5.72%
OCF(TTM)1.99
OCFY8.28%
SpS16.3
BVpS3.01
TBVpS-10.51
PEG (NY)1.77
PEG (5Y)N/A
Graham Number9.59
Profitability
Industry RankSector Rank
ROA 5.33%
ROE 39.35%
ROCE 12.89%
ROIC 11.29%
ROICexc 11.52%
ROICexgc 38.19%
OM 15.61%
PM (TTM) 7.26%
GM 28.36%
FCFM 8.4%
ROA(3y)14.38%
ROA(5y)N/A
ROE(3y)62.08%
ROE(5y)N/A
ROIC(3y)23.71%
ROIC(5y)N/A
ROICexc(3y)24.7%
ROICexc(5y)N/A
ROICexgc(3y)89.31%
ROICexgc(5y)N/A
ROCE(3y)27.06%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.12%
OM growth 5YN/A
PM growth 3Y-10.09%
PM growth 5YN/A
GM growth 3Y-1.93%
GM growth 5YN/A
F-Score6
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 4.15
Debt/FCF 9.18
Debt/EBITDA 4.03
Cap/Depr 110.85%
Cap/Sales 3.77%
Interest Coverage 2.98
Cash Conversion 64.02%
Profit Quality 115.74%
Current Ratio 1.2
Quick Ratio 1.2
Altman-Z 1.95
F-Score6
WACC8.09%
ROIC/WACC1.4
Cap/Depr(3y)84.37%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.64%
Cap/Sales(5y)N/A
Profit Quality(3y)135.77%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.71%
EPS Next Y9.96%
EPS Next 2Y11.84%
EPS Next 3Y12.23%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%15.92%
Revenue Next Year7.53%
Revenue Next 2Y6.75%
Revenue Next 3Y6.93%
Revenue Next 5YN/A
EBIT growth 1Y-39%
EBIT growth 3Y-0.08%
EBIT growth 5YN/A
EBIT Next Year39.66%
EBIT Next 3Y17.62%
EBIT Next 5Y14.94%
FCF growth 1Y21.47%
FCF growth 3Y-3.19%
FCF growth 5YN/A
OCF growth 1Y17.23%
OCF growth 3Y-1.87%
OCF growth 5YN/A

CONCENTRA GROUP HOLDINGS PAR / CON FAQ

What is the fundamental rating for CON stock?

ChartMill assigns a fundamental rating of 4 / 10 to CON.


What is the valuation status of CONCENTRA GROUP HOLDINGS PAR (CON) stock?

ChartMill assigns a valuation rating of 5 / 10 to CONCENTRA GROUP HOLDINGS PAR (CON). This can be considered as Fairly Valued.


Can you provide the profitability details for CONCENTRA GROUP HOLDINGS PAR?

CONCENTRA GROUP HOLDINGS PAR (CON) has a profitability rating of 7 / 10.


How financially healthy is CONCENTRA GROUP HOLDINGS PAR?

The financial health rating of CONCENTRA GROUP HOLDINGS PAR (CON) is 3 / 10.


Can you provide the expected EPS growth for CON stock?

The Earnings per Share (EPS) of CONCENTRA GROUP HOLDINGS PAR (CON) is expected to grow by 9.96% in the next year.